WO2021071806A1
|
|
Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers
|
WO2021071832A1
|
|
Aryl heterobicyclic compounds as kv1.3 potassium shaker channel blockers
|
WO2021071802A1
|
|
Aryl heterocyclic compounds as kv1.3 potassium shaker channel blockers
|
WO2021071821A1
|
|
Arylmethylene aromatic compounds as kv1.3 potassium shaker channel blockers
|
WO2021071803A1
|
|
Aryl heterobicyclic compounds as kv1.3 potassium shaker channel blockers
|
WO2021071812A1
|
|
Arylmethylene heterocyclic compounds as kv1.3 potassium shaker channel blockers
|
WO2020243440A1
|
|
Molecular graph generation from structural features using an artificial neural network
|
BR112020019385A2
|
|
SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE OF THE SAME
|
EP3681499A1
|
|
Compounds as ras inhibitors and use thereof
|
US2020375996A1
|
|
Method of treating neurodegenerative disorders by rescuing alpha-synuclein toxicity
|
EP3218833A2
|
|
Suppressing interaction between bonded particles
|
US2015365329A1
|
|
Inverse weighted arbitration
|
US2015051090A1
|
|
Methods for in silico screening
|
JP2014170556A
|
|
Parallel calculation architecture for calculating particle interaction
|
US2014282576A1
|
|
Event-driven computation
|
WO2013130808A1
|
|
Methods for screening voltage gated proteins
|
US2010125718A1
|
|
Parallel analysis of time series data
|
US2009046727A1
|
|
Routing with virtual channels
|
WO2008118789A2
|
|
Computation of multiple body interactions
|
US2008082303A1
|
|
Numerical techniques for dynamics simulation
|